絞り込み

16421

広告

「abatacept」の検索結果

3189件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Immunotherapy for cardiovascular disease.

Randomized Clinical Trial Design to Assess Abatacept in Resistant Nephrotic Syndrome.

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting.

Selective CD28 blockade attenuates CTLA-4-dependent CD8+ memory T cell effector function and prolongs graft survival.

Abatacept Improves Skin-score and Reduces Lesions in Patients with Localized Scleroderma: A Case Series.

Cost-effectiveness of early treatment of ACPA-positive rheumatoid arthritis patients with abatacept.

Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review.

Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study.

Comparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis: a systematic review and network meta-analysis.

Biologics in inflammatory and immunomediated arthritis.

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.

Effects of CTLA4-Ig on human monocytes.

Abatacept efficacy in steroid-resistant minimal-change disease revealed by the speed of proteinuria reduction after the start of abatacept
.

Degree of prescriber's knowledge about variability in biological drugs "innovators" in manufacturing process.

Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.

Correlation of hypogammaglobulinaemia with proteinuria, and the relationship between hypogammaglobulinaemia and infection in active lupus nephritis.

Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial.

A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population.

Dosing down and then discontinuing biologic therapy in rheumatoid arthritis: a review of the literature.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります